News

Assessing the risk of excess folic acid intake

Ana Maria Rodriguez
By Ana Maria Rodriguez
March 18, 2023

It is well established that folic acid supplementation can significantly reduce the risk of birth defects, including neural tube defects like spina bifida, the most common birth defect of the central nervous system and the second most common of all structural birth defects. More than 80 nations, including the U.S. 25 years ago, have established mandated folic acid food fortification programs, which have been successful.

“However, there is a lack of research on whether excessive folic acid intake has the potential to harm human beings,” said co-corresponding author, Dr. Richard H. Finnell, William T. Butler, M.D., Distinguished Chair Professor in the Center for Precision Environmental Health and the departments of molecular and cellular biologymolecular and human genetics and medicine at Baylor College of Medicine.

There are reports of adverse effects associated with high folate intake in humans. In this study published in the journal Cell Discovery, Finnell and his colleagues investigated in an animal model the potential effect of folic acid supplementation on DNA mutation rates and other genetic modifications such as whole genome methylation, which can change how much of any given gene product gets expressed in cells.

The animals received one of three folic-acid-supplemented diets: folic acid low, folic acid control and folic acid high. “Compared to the mutation frequency of the folic acid-control diet group, that of the folic acid-low diet group increased two-fold and the folic acid-high diet group increased 1.8 fold,” Finnell said.

The researchers found that DNA repair genes were significantly hypermethylated in the folic acid-high diet, suggesting that excess folic acid supplementation may affect the mutation rate by reducing the expression of DNA repair genes and consequently impairing DNA repair activity. Understanding these mechanisms requires further investigation.

“The effects of high- or low-folic acid diets should be confirmed in human population in future studies,” Finnell said. “Our data supports that folic acid supplementation should be restricted to an ideal benefit range. What we have here is a “Goldilocks Effect”: Too little or too much of a good thing (folic acid) may not be such a good thing.”

This article first appeared on the Baylor College of Medicine news site. Read the original.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Ana Maria Rodriguez
Ana Maria Rodriguez

Ana Maria Rodriguez is lead science writer at Baylor College of Medicine. She is the editor of From the Labs, Baylor’s science blog spotlighting the newest and most interesting research information from the bench at the College, and one of its main contributors.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Differences in pili structure modulate bacterial behavior
Journal News

Differences in pili structure modulate bacterial behavior

April 14, 2026

Researchers demonstrate how small changes in the structure of hair-like protein appendages can affect the behavior of Acinetobacter bacteria.

Cholesterol regulatory genes predict liver transplant outcomes
Journal News

Cholesterol regulatory genes predict liver transplant outcomes

April 10, 2026

Researchers identify a link between cholesterol-regulating genes and liver transplant success, which could improve donor screening and patient outcomes.

Lipid signatures for a rare neurological disorder
Journal News

Lipid signatures for a rare neurological disorder

April 10, 2026

Researchers find distinct lipid patterns linked to a rare autoimmune neurological disorder, offering hope for effective targeted therapies for patients.

Disease-linked mutations disrupt protein phase behavior
Journal News

Disease-linked mutations disrupt protein phase behavior

April 9, 2026

Researchers find that pathogenic missense mutations are enriched threefold in phrase-separating intrinsically disordered regions of proteins.

The dual role of asprosin in chronic fatty liver disease
Journal News

The dual role of asprosin in chronic fatty liver disease

April 8, 2026

Researchers uncover a hormone called asprosin that may serve as a potential biomarker for the diagnosis of chronic fatty liver disease and monitoring disease progression.

Novel inhibitor targets RAS-driven cancers
Journal News

Novel inhibitor targets RAS-driven cancers

April 7, 2026

Researchers in Louisville identify a small-molecule drug that blocks RALGEF signaling downstream of mutant RAS. The compound suppresses tumor growth with low toxicity, revealing a new therapeutic strategy for RAS-driven malignancies.